Succinate Dehydrogenase (SDH) D Subunit (SDHD) Inactivation in a Growth-Hormone-Producing Pituitary Tumor: A New Association for SDH?
Author(s) -
Paraskevi Xekouki,
Karel Pacák,
Madson Q. Almeida,
Christopher A. Wassif,
Pierre Rustin,
Maria Nesterova,
Maria De La Luz Sierra,
Joey C. Matro,
Evan Ball,
Monalisa Ferreira Azevedo,
A. A. Horvath,
Charalampos Lyssikatos,
Martha Quezado,
Nicholas J. Patronas,
Barbara Ferrando,
Barbara Pasini,
Aristides Lytras,
G. Tolis,
Constantine A. Stratakis
Publication year - 2011
Publication title -
the journal of clinical endocrinology and metabolism
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.206
H-Index - 353
eISSN - 1945-7197
pISSN - 0021-972X
DOI - 10.1210/jc.2011-1179
Subject(s) - sdhd , sdhb , acromegaly , pheochromocytoma , loss of heterozygosity , endocrinology , medicine , germline mutation , sdha , cancer research , pituitary adenoma , biology , adenoma , mutation , genetics , succinate dehydrogenase , hormone , allele , mitochondrion , growth hormone , gene
Mutations in the subunits B, C, and D of succinate dehydrogenase (SDH) mitochondrial complex II have been associated with the development of paragangliomas (PGL), gastrointestinal stromal tumors, papillary thyroid and renal carcinoma (SDHB), and testicular seminoma (SDHD).
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom